克拉迪宾在复发性多发性硬化症中的临床和机械效应:MAGNIFY-MS研究的2年结果
Klaus Schmierer1,2, Heinz Wiendl3,4, Frederik Barkhof5,6
1The Blizard Institute, Centre for Neuroscience, Surgery and Trauma, Faculty of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK.
Therapeutic advances in neurological disorders
|August 4, 2025
概括
克拉迪宾片降低了高度活跃复发性多发性硬化症患者的疾病活性和炎症和神经轴损伤的生物标志物. 这种口服治疗在两年内在减少复发和改善关键标志物方面表现出持续的有效性.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 克拉迪片 (CladT) 是一种口服前药物,可以穿过血脑屏障.
- 它们会影响中枢神经系统中疾病进展的生物标志物.
研究的目的:
- 用CladT.治疗的高活性复发性多发性硬化症 (pwRMS) 患者的疾病活性描述.
- 评估临床结果和疾病进展的生物标志物.
主要方法:
- MAGNIFY-MS 是一个IV期,开放标签,单臂试验,包括CSF和OCT子研究.
- 参与者根据基线的橄克隆带 (OCB) 状态进行了分层.
- 分析了NEDA-3,NEPAD和ARR的后勤回归;评估了生物标志物变化 (OCB,KFLC,IgG,IgM,NfL) 和OCT测量.
主要成果:
- 在第二年,NEDA-3率为整体64.1%,NEPAD为60.2%.
- 年化复发率 (ARR) 总体为0.09 (0.04在未经治疗的患者中).
- 在具有≥2个OCB的参与者中,76.5%观察到OCB的减少;NfL显示持续减少,OCT显示没有视网膜神经纤维稀释.
结论:
- 在pWRMS中,CladT治疗降低了疾病活性.
- 导管内炎症和神经轴损伤的生物标志物显著减少.
- 该研究强调了CladT在管理高度活跃的复发性MS的有效性.
相关概念视频
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
58
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
58
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K


